4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-047417
Director bought 6,250 shares at $15.97 ($99,813)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tullman Stephen A. Director | 2018-08-15 | Purchase | +6,250 | $15.97 | $99,813 | 163,757 | D |
| Open-market purchases · 6,250 sh · avg $15.97 · $99,813 | |||||||
Loading xslF345X03/doc4.xml…